The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Stable Anti-Ifnar1 Formulation - EP3769781

The patent EP3769781 was granted to Astrazeneca on Apr 19, 2023. The application was originally filed on Aug 18, 2016 under application number EP20174805A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3769781

ASTRAZENECA
Application Number
EP20174805A
Filing Date
Aug 18, 2016
Status
Granted And Under Opposition
Mar 17, 2023
Publication Date
Apr 19, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDJan 18, 2024MAIWALDADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2011059078
DESCRIPTIONUS4816567
DESCRIPTIONUS7662381
EXAMINATIONUS2014127227
OPPOSITIONWO2009100309
OPPOSITIONWO2013063510
OPPOSITIONWO2014036071
OPPOSITIONWO2014036076
OPPOSITIONWO2014066468
OPPOSITIONWO2016034648
OPPOSITIONWO2016109822
OPPOSITIONWO2017031288
SEARCHWO2009100309

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents